LOS ANGELES–(BUSINESS WIRE)–Retinoblastoma is a rare pediatric cancer, with approximately 250-300 new cases per year in the United States and 8,000 worldwide. The cancer grows within the retina, a thin layer of cells at the back of the eye, and is us…
Warby Parker to Announce First Quarter 2024 Financial Results on May 9, 2024
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the first quarter ended March 31, 2024 will be released before mar…
Introducing RevEngage: Patient Communication Simplified
SAN DIEGO–(BUSINESS WIRE)–RevolutionEHR, the leading provider of optometry practice management software, has released its robust new patient engagement solution, RevEngage.
No association found between vaccination and corneal graft rejection
A matched case-control study performed at Kaiser Permanente Southern California found no evidence to suggest an association between vaccination and corneal graft rejection.Cases of graft rejection following administration of the SARS-CoV-2 and other va…
Alivi Health Unveils Innovative Vision Program, Setting a New Standard in Healthcare Offerings
MIAMI–(BUSINESS WIRE)–Alivi Health, a leading provider of transportation, card-based, and specialty benefits, unveils a new Vision Program, a groundbreaking service designed to elevate medical centers’ offerings and enhance member satisfaction. The c…
VIDEO: Sight Sciences shares updates on GEMINI, SAHARA trials
BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Matt Link, chief commercial officer of Sight Sciences, shares information on the company’s clinical trials.“Specifically exciting for us here is the unveiling of two new pieces of clini…